...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of cosmetic and laser therapy >A case report of combination treatment with potassium-titanyl phosphate laser and brimonidine topical gel in erythematotelangiectatic rosacea
【24h】

A case report of combination treatment with potassium-titanyl phosphate laser and brimonidine topical gel in erythematotelangiectatic rosacea

机译：磷酸钾 - 磷酸钾激光和吡隆局局部凝胶中磷酸钾局部凝胶术治疗的案例报告

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Laser therapies have been shown to provide symptom improvement in patients with erythema and telangiectasia of rosacea; however, they are associated with side effects such as erythema. Combinatorial treatment with pharmacological agents and laser have demonstrated better efficacy, fewer side effects and continued long-term remission compared with monotherapies. A case of moderate facial erythema that responded well to combination treatment with brimonidine 3 mg/g gel and a treatment course of potassium-titanyl phosphate (KTP) laser therapy is presented, showing a reduction from baseline, maintained after final laser session, by applying brimonidine 3 mg/g gel daily. Using brimonidine 3 mg/g gel to target post-laser treatment erythema is highly effective in minimising refractory erythema. Continued use of brimonidine 3 mg/g gel provides a sustained reduction of erythema, increasing the visibility of other signs and symptoms of rosacea that may be present. This can facilitate the treatment of these additional signs and symptoms.
机译：已显示激光疗法，以提供患者的红斑和毛动作用的患者的症状改善;然而，它们与诸如红斑的副作用相关联。与药物药物和激光的组合治疗表明，与单极相比，持续的副作用和持续长期缓解效果更好。提出了用溴胺3mg / g凝胶和磷酸钾 - 磷酸钾（KTP）激光治疗的治疗良好的适度面部红斑的案例，显示出从基线的减少，通过施用，在最终激光会议之后维持二月红细胞3 mg / g每日凝胶。使用硫代尼胺3mg / g凝胶至靶激光治疗后激光治疗红斑在最小化耐火性红斑中具有高效。继续使用吡尼尼胺3 mg / g凝胶可以持续减少红斑减少，增加可能存在的其他迹象和症状的可见性。这可以促进治疗这些额外的症状和症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号